To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Counterfeit Manufacturing
Tuesday 14th December 2021

Asked by: Allan Dorans (Scottish National Party - Ayr, Carrick and Cumnock)

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate his Department has made on the impact of counterfeit and pirated goods on the UK economy.

Answered by George Freeman

In a study published in 2019 the OECD estimate the total volume of forgone sales for UK wholesalers and retailers due to counterfeit and pirated products smuggled into the UK in 2016 is £9.2 billion.


Speech in Commons Chamber - Tue 09 Feb 2021
Oral Answers to Questions

Speech Link

View all Allan Dorans (SNP - Ayr, Carrick and Cumnock) contributions to the debate on: Oral Answers to Questions

Speech in Commons Chamber - Tue 09 Feb 2021
Oral Answers to Questions

Speech Link

View all Allan Dorans (SNP - Ayr, Carrick and Cumnock) contributions to the debate on: Oral Answers to Questions

Speech in Westminster Hall - Thu 19 Nov 2020
Fuel Poverty and Energy Price Caps

Speech Link

View all Allan Dorans (SNP - Ayr, Carrick and Cumnock) contributions to the debate on: Fuel Poverty and Energy Price Caps

Written Question
Coronavirus: Research
Friday 18th September 2020

Asked by: Allan Dorans (Scottish National Party - Ayr, Carrick and Cumnock)

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support research into understanding the biological mechanisms of long term covid-19 symptoms.

Answered by Amanda Solloway

Understanding the biological mechanisms of COVID-19 and its longer-term impacts is a priority topic in UK Research and Innovation’s (UKRI) research response. In partnership with National Institute for Health Research (NIHR), UKRI has announced an £8.4 million project that will investigate the physical and mental health impacts of hospitalised patients. The Post-HOSPitalisation COVID-19 (PHOSP-COVID) study, led by Professor Chris Brightling from the University of Leicester, aims to recruit 8,000 patients from across the UK. This will make it one of the world’s largest studies into the long-term health consequences of COVID-19. Results from the study will inform the development of new and better measures to treat and rehabilitate patients hospitalised with COVID-19.

Additional supported work includes a £0.6 million award to Dr James Peters at Imperial College London for the mechanisms underlying the excessive inflammatory response developed in a subset of COVID-19 patients, and a £0.8 million award to Professor John Greenwood Leeds Teaching Hospitals NHS Trust, who will use magnetic resonance imaging to diagnose and understand cardiac injuries in COVID-19 patients. These awards were made through the UKRI-NIHR COVID-19 Rapid Response Rolling Call.


Written Question
Coronavirus: Research
Thursday 17th September 2020

Asked by: Allan Dorans (Scottish National Party - Ayr, Carrick and Cumnock)

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to support research into the efficacy of a covid-19 vaccine in older people.

Answered by Amanda Solloway

The University of Oxford / Astra Zeneca Phase 3 trial includes arms that specifically looks at safety and efficacy of the vaccine in those aged between 56 – 69 and over 70. For these groups, researchers are assessing the immune response to the vaccine in people of different ages, to find out if there is variation in how well the immune system responds in older people. Other vaccine developers that the Government are working with may also decide to include specific groups such as these in their trials.

In addition to the work that vaccine developers are undertaking, the Government has funded the NHS Registry, developed by the National Institute for Health Research (NIHR). This national registry is encouraging people who may be disproportionately affected by COVD19, such as older people, older people with underlying health conditions and people from different ethnic groups, to volunteer for clinical trials. This includes supporting the development of communications materials to provide information on taking part in COVID 19 vaccine trials via the NIHR website (Be Part of Research).


Written Question
Horizon 2020
Thursday 17th September 2020

Asked by: Allan Dorans (Scottish National Party - Ayr, Carrick and Cumnock)

Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent steps his Department has taken to prepare for the UK potentially not associating to Horizon Europe after the transition period.

Answered by Amanda Solloway

In tandem with our negotiations to associate to EU programmes we, as a responsible government, are developing alternative schemes to support international research and innovation collaboration. If we do not formally associate to Horizon Europe, we will implement ambitious alternatives as quickly as possible from January 2021 and address the funding gap. We will launch an ambitious new Discovery Fund offering sizeable grants over long periods of time to early, mid and late-career researchers, whether already in the UK or coming here from anywhere in the world, to pursue ground-breaking research. We will scale up and enhance prestigious domestic schemes, providing funding to allow UK researchers and innovators to seize opportunities and to allow our institutions to attract and retain international talent and we will make funding available to allow UK partners to participate in European schemes open to third countries.


Speech in Commons Chamber - Tue 21 Jul 2020
Oral Answers to Questions

Speech Link

View all Allan Dorans (SNP - Ayr, Carrick and Cumnock) contributions to the debate on: Oral Answers to Questions

Speech in Commons Chamber - Tue 21 Jul 2020
Oral Answers to Questions

Speech Link

View all Allan Dorans (SNP - Ayr, Carrick and Cumnock) contributions to the debate on: Oral Answers to Questions

Speech in Commons Chamber - Mon 04 May 2020
Oral Answers to Questions

Speech Link

View all Allan Dorans (SNP - Ayr, Carrick and Cumnock) contributions to the debate on: Oral Answers to Questions